Cell Therapy for Retinal Dystrophies: From Cell Suspension Formulation to Complex Retinal Tissue Bioengineering
Retinal degeneration is an irreversible phenomenon caused by various disease conditions including age-related macular degeneration (AMD) and retinitis pigmentosa (RP). During the course of these diseases, photoreceptors (PRs) are susceptible to degeneration due to their malfunctions or to a primary...
Saved in:
Main Authors: | Karim Ben M’Barek, Christelle Monville |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2019/4568979 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retinitis Pigmentosa with EYS Mutations Is the Most Prevalent Inherited Retinal Dystrophy in Japanese Populations
by: Yuuki Arai, et al.
Published: (2015-01-01) -
A platform for Bioengineering Tissue Membranes from cell spheroids
by: Quang Bach Le, et al.
Published: (2025-04-01) -
Retinal Protection of New Nutraceutical Formulation
by: Luca Rosario La Rosa, et al.
Published: (2025-01-01) -
Mesenchymal Stem Cells and Tissue Bioengineering Applications in Sheep as Ideal Model
by: Talita D’Paula Tavares Pereira Muniz, et al.
Published: (2024-01-01) -
Evaluation for Retinal Therapy for RPE65 Variation Assessed in hiPSC Retinal Pigment Epithelial Cells
by: Benjamin M. Nash, et al.
Published: (2021-01-01)